Effect of Bempedoic Acid vs Placebo Added to Statins on LDL-C in Patients at High Risk for CVD

This randomized clinical trial compares the efficacy of bempedoic acid, an experimental drug that inhibits an enzyme upstream of HMG-CoA reductase, vs placebo for lowering levels of low-density lipoprotein cholesterol (LDL-C) in patients at high cardiovascular risk with ongoing hypercholesterolemia receiving maximally tolerated lipid-lowering therapy.
Source: JAMA - Category: General Medicine Source Type: research